Haldol

Haldol is a medication containing the active ingredient haloperidol, supplied in oral dosage forms and marketed in the European Union. It belongs to the butyrophenone class of antipsychotics and works as a dopamine D2 receptor antagonist, used under prescription for several psychiatric conditions. The drug is typically prescribed by a qualified healthcare professional and may be available in various strengths depending on the formulation and dosage regimens.

Haldol is indicated for the management of several psychiatric disorders where dopamine dysregulation is implicated.

- Schizophrenia (including maintenance therapy) - Acute psychotic episodes - Manic episodes associated with bipolar disorder - Tourette syndrome (to reduce motor and vocal tics) - Severe agitation in emergency settings

Side effects of haloperidol vary in frequency and severity.

Common: - Drowsiness or sedation - Extrapyramidal symptoms (e.g., tremor, rigidity) - Dry mouth - Constipation

Serious: - Neuroleptic malignant syndrome - Tardive dyskinesia - Cardiac arrhythmias (QT prolongation)

When prescribing haloperidol, clinicians consider several safety factors to minimize risk.

- Assess patient history for cardiovascular disease - Monitor for signs of extrapyramidal reactions - Use the lowest effective dose, especially in elderly patients - Evaluate potential pregnancy or lactation status - Review liver and kidney function before dose adjustments - Exercise caution in patients with a history of seizures

Haloperidol may interact with other medications, altering its effectiveness or safety profile.

Avoid: - Other dopamine antagonists (e.g., metoclopramide) - Medications that prolong QT interval (e.g., certain antiarrhythmics) - Strong CYP3A4 inhibitors (e.g., ketoconazole)

Use with caution: - CNS depressants such as benzodiazepines or alcohol - Anticholinergic agents (may mask extrapyramidal symptoms) - Antihypertensive drugs (potential additive hypotensive effect)